Burrell Terry-Ann Insider Trades

Insider Trading History

Track insider trading activity for Burrell Terry-Ann. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $238k 71,254 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 1,843 shares
$7.46
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $232k 69,411 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 26,193 shares
$8.59
$3.34
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $2.55M 82,637 shares
Last Trade
Apr 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$535k 25,000 shares
$21.38
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $2.17M 70,137 shares
Last Trade
Apr 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$175k 5,446 shares
$32.12
$30.89
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $188k 56,314 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7k 1,467 shares
$9.37
$3.34
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $2.33M 75,583 shares
Last Trade
Mar 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$909k 27,500 shares
$33.04
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $1.7M 55,000 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 55,000 shares
$24.40
$30.89
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $183k 54,847 shares
Last Trade
Jul 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$104k 8,275 shares
$12.59
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $211k 63,122 shares
Last Trade
Jul 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.1k 3,157 shares
$12.08
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $221k 66,279 shares
Last Trade
Jul 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.1k 3,195 shares
$13.18
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $493k 147,545 shares
Last Trade
Jul 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$273k 24,302 shares
$11.25
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $232k 69,474 shares
Last Trade
Jul 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$949k 78,071 shares
$12.15
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $84.2k 25,224 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 25,224 shares
$8.92
$3.34
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $574k 171,847 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 12,612 shares
$8.92
$3.34
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $1.46M 47,117 shares
Last Trade
Apr 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.6k 2,186 shares
$29.09
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $1.52M 49,303 shares
Last Trade
Apr 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.4k 2,454 shares
$30.31
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $1.58M 51,277 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$612k 20,000 shares
$30.62
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $618k 20,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$869k 20,000 shares
$43.45
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $1.24M 40,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.74M 40,000 shares
$43.45
$30.89
Beam Therapeutics
Beam Therapeutics BEAM
Chief Financial Officer
Holding Value $966k 31,277 shares
Last Trade
Jan 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.63M 36,152 shares
$45.08
$30.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up